成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 22204-53-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 22204-53-1
Chemical Structure| 22204-53-1
Structure of 22204-53-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 22204-53-1 ]

Related Doc. of [ 22204-53-1 ]

Alternatived Products of [ 22204-53-1 ]
Product Citations

Product Citations      Expand+

?wi?tek, Ewelina ; Janus, Ewa ; Ossowicz-Rupniewska, Paula , et al. DOI: PubMed ID:

Abstract: In the study, the modification of (NAP) with esters of four amino acids (AAs): (GlyOiPr), (ProOiPr), (LeuOiPr), and (SerOiPr) isopropyl ester was performed to improve water solubility and enhance the permeation of the drug through the skin in comparison to the parent NAP. The NAP derivatives were prepared using the equimolar ratio of the components. In-depth NMR and FTIR analysis revealed that the salts formed with the proton transfer from the carboxylic group of NAP to the amine group of the appropriate AA ester. The NAP salts exhibited improved solubility in water and PBS solution (pH 7.4) when compared to parent NAP. The values of the partition coefficient (log PO/W) for prepared salts were lower than for NAP, however, the salts maintained hydrophobic character determined by the positive values of log P. The In vitro permeation through the pig skin performed in Franz diffusion cells showed that all NAP salts exhibited a higher cumulative mass of permeated NAP (Q24h) than the parent acid. The highest permeation value was noted for [ProOiPr][NAP], with a pseudo-steady state flux (Jss) 32.5?μg NAP cm?2h?1, and Q24h?=?246.4?μg NAP cm?2, it was 2.5?% of the applied dose. Moreover, topical preparations with [ProOiPr][NAP] and NAP were prepared based on two vehicles ? Celugel? and Pentravan?- approved in pharmacy recipes. The permeation experiments through the Strat-M? showed, that both the Jss and Q24h of permeated drug from preparations containing [ProOiPr][NAP], were statistically several times greater than from the respective preparations with the unmodified acid. Additionally, preparations with [ProOiPr][NAP] provided significantly improved permeation of NAP than two commercial preparations, one of which contained as the acid and the other - as the sodium salt.

Keywords: amino acid isopropyl esters ; ; nonsteroidal anti-inflammatory drug ; skin ; permeation ; topical compositions

Purchased from AmBeed:

Tonduru, Arun Kumar ; Maljaei, Seyed Hamed ; Adla, Santosh Kumar , et al. DOI: PubMed ID:

Abstract: OATP1C1 (organic anion-transporting polypeptide 1C1) transports thyroid hormones, particularly thyroxine (T4), into human astrocytes. In this study, we investigated the potential of utilizing OATP1C1 to improve the delivery of anti-inflammatory drugs into glial cells. We designed and synthesized eight novel prodrugs by incorporating T4 and 3,5-diiodo-L-tyrosine (DIT) as promoieties to selected anti-inflammatory drugs. The prodrug uptake in OATP1C1-expressing human U-87MG glioma cells demonstrated higher accumulation with T4 promoiety compared to those with DIT promoiety or the parent drugs themselves. In silico models of OATP1C1 suggested dynamic binding for the prodrugs, wherein the pose changed from vertical to horizontal. The predicted binding energies correlated with the transport profiles, with T4 derivatives exhibiting higher binding energies when compared to prodrugs with a DIT promoiety. Interestingly, the prodrugs also showed utilization of oatp1a4/1a5/1a6 in mouse primary astrocytes, which was further supported by docking studies and a great potential for improved brain drug delivery.

Purchased from AmBeed: ; ; ; ; ; ;

Klebeko, Joanna ; Ossowicz-Rupniewska, Paula ; Nowak, Anna , et al. DOI:

Abstract: Herein, we investigated the effect of pairing the L-amino acid alkyl (Pr, iso-Pr, or butyl) ester on the formation of API-ILs. The novel salts of NSAIDs (non-steroidal anti-inflammatory drugs) obtained from biodegradable cations were synthesized and characterised by NMR (NMR), Fourier transform IR spectroscopy (FT-IR), and X-ray powder diffraction (XRD) methods. The influence of structure counterions for APIs from the NSAIDs group on their physicochem. properties was studied in detail. The comprehensive effects of cation structure on skin permeation, accumulation, and antioxidant activity of API-ILs were also evaluated. These results demonstrated that L-amino acid alkyl esters can be successfully used to synthesize API-ILs further used in topical formulations with anti-ageing, anti-inflammatory, or photoprotective effects.

Keywords: Nonsteroidal anti-inflammatory drug ; Amino acid ester salts ; Ionic liquids ; Topical delivery ; Skin barrier

Purchased from AmBeed: ;

Rakoczy, Rafal ; Nowak, Anna ; Konopacki, Maciej , et al. DOI: PubMed ID:

Abstract: The paper presents a method of increasing the permeability of various active substances through the skin by means of a rotating magnetic field. The study used 50 Hz RMF and various active pharmaceutical ingredients (APIs) such as caffeine, ibuprofen, naproxen, ketoprofen, and paracetamol. Various concentrations of active substance solutions in ethanol were used in the research, corresponding to those in com. preparations Each experiment was conducted for 24 h. It was shown that, regardless of the active compound used, an increase in drug transport through the skin was observed with RMF exposure. Furthermore, the release profiles depended on the active substance used. Exposure to a rotating magnetic field has been shown to effectively increase the permeability of an active substance through the skin.

Keywords: Electromagnetic field ; Rotating magnetic field ; Active pharmaceutical ingredients ; Transdermal drug delivery ; Skin barrier

Purchased from AmBeed: ;

Swiatek, Ewelina ; Ossowicz-Rupniewska, Paula ; Janus, Ewa , et al. DOI: PubMed ID:

Abstract: The paper presents the synthesis, full identification, and characterization of new salts-L-proline alkyl ester naproxenates [ProOR][NAP], where R was a chain from Et to Bu (including isopropyl). All obtained compounds were characterized by NMR (NMR), Fourier transform IR spectroscopy (FTIR), X-ray powder diffractometry (XRD), and in vitro dissolution studies. The sp. rotation, phase transition temperatures (m.p.), and thermal stability were also determined In addition, their lipophilicity, permeability, and accumulation in pigskin were determined Finally, toxicity against mouse L929 fibroblast cells was tested. The obtained naproxen derivatives showed improved solubility and higher absorption of drug mols. by biol. membranes. Their lipophilicity was lower and increased with the increase in the alkyl chain of the ester. The derivative with iso-Pr ester had the best permeability through pigskin. The use of L-proline iso-Pr ester naproxenate increased the permeation of naproxen through the skin almost four-fold. It was also shown that the increase in permeability is not associated with addnl. risk: all compounds had a similar effect on cell viability as the parent naproxen.

Keywords: amino acid ; ionic liquids ; naproxen ; nonsteroidal anti-inflammatory drug ; skin barrier ; transdermal drug delivery

Purchased from AmBeed:

Product Details of [ 22204-53-1 ]

CAS No. :22204-53-1 MDL No. :MFCD00010500
Formula : C14H14O3 Boiling Point : -
Linear Structure Formula :CH3OC10H6CHCH3COOH InChI Key :-
M.W : 230.26 Pubchem ID :-
Synonyms :
(S)-Naproxen;(+)-Naproxen;Napratec;Naposin;CG 3117
Chemical Name :(S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid

Calculated chemistry of [ 22204-53-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.21
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 66.79
TPSA : 46.53 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.33 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.95
Log Po/w (XLOGP3) : 3.34
Log Po/w (WLOGP) : 3.04
Log Po/w (MLOGP) : 2.57
Log Po/w (SILICOS-IT) : 2.9
Consensus Log Po/w : 2.76

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -3.61
Solubility : 0.0566 mg/ml ; 0.000246 mol/l
Class : Soluble
Log S (Ali) : -3.99
Solubility : 0.0233 mg/ml ; 0.000101 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.02
Solubility : 0.0221 mg/ml ; 0.0000962 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.85

Safety of [ 22204-53-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P201-P202-P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P308+P313-P332+P313-P337+P313-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H361 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22204-53-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 22204-53-1 ]

[ 22204-53-1 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 934343-39-2 ]
  • [ 50-00-0 ]
  • [ 6642-30-4 ]
  • [ 22204-53-1 ]
  • 2
  • [ 6938-07-4 ]
  • [ 22204-53-1 ]
  • [ 1195100-16-3 ]
  • 3
  • C33H40N4O12 [ No CAS ]
  • [ 22204-53-1 ]
  • [ 139110-80-8 ]
  • 4
  • 5-acetamido-4-(3-(2-(6-methoxynaphthalen-2-yl)propanoyl))guanidino-6-(1,2,3-trihydroxypropyl)-4,5-dihydro-6H-pyran-2-carboxylic acid [ No CAS ]
  • [ 22204-53-1 ]
  • [ 139110-80-8 ]
Recommend Products
Same Skeleton Products

Technical Information

Historical Records
; ;